 REGIMEN: Enrolled patients will be randomized to receive either the vaccine gp120NefTatAS02A 10 individuals, the AS02A adjuvant only 5 individuals or a placebo 5 individuals. Injections will be administered IM at weeks 0, 4, and 12. 